Stockreport

Sierra Oncology Announces Closing of $103 Million Public Offering and Changes to its Board of Directors

Sierra Oncology, Inc.  (SRRA) 
Last sierra oncology, inc. earnings: 3/3 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sierraoncology.com
PDF VANCOUVER, Nov. 26, 2019 /PRNewswire/ - Sierra Oncology, Inc. (Nasdaq: SRRA), a late-stage drug development company focused on the development and commercialization of m [Read more]